Latest News

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

Keywords:

Study Identifies Possible New Combination Chemotherapy for Patients with Advanced Prostate Cancer

PaulCornheadshot.jpg

A role for combination therapy using two or more chemotherapy agents at the same time has not been well studied. This week, however, results of a clinical trial presented at the American Society of Clinical Oncology meeting by researchers at The University of Texas MD Anderson Cancer Center may change the perspective on a role for combination chemotherapy in advanced disease.

Medicine

Channels:

Removing More Tissue During Breast Cancer Surgery Reduces by Half the Need for Second Procedure

shutterstock_243605839.jpg

Removing more tissue during a partial mastectomy could spare thousands of breast cancer patients a second surgery, according to a Yale Cancer Center study. The findings were published online May 30 in the New England Journal of Medicine and presented at the 2015 Annual Meeting of the American Society of Clinical Oncology in Chicago.

Medicine

Channels:

Keywords:

Mount Sinai Researchers to Present Key Cancer Trial Data at ASCO

Mount Sinai Health System faculty will be presenting research updates on a lymphoma vaccine clinical trial, the best dosing for a drug against metastatic cancer, and new treatment strategies in relapsed multiple myeloma at the American Society of Clinical Oncology (ASCO) annual meeting, May 29 – June 2, 2015, in Chicago.

Medicine

Channels:

Keywords:

Practice-Changing Study Offers New Option for Tough Breast Cancer Cases

A new phase 3 study in some of the most difficult-to-treat patients, women with endocrine-resistant disease, showed that the newly approved drug, palbociclib, more than doubled the time to cancer recurrence for women with hormone-receptor (HR+) positive metastatic breast cancer.

Medicine

Channels:

Keywords:

Targeted Drug Can ‘Diminish the Suffering’ of Myelofibrosis Say Mayo Clinic Researchers

CHICAGO — Use of the targeted agent pacritinib significantly reduced the symptoms and burden of advanced myelofibrosis in patients, says a Mayo Clinic researcher who co-led PERSIST-1, the worldwide phase 3 clinical trial that tested the therapy. Specifically, pacritinib substantially reduced severe enlargement of the spleen, a typical feature of advanced myelofibrosis, in more than 20 percent of patients and alleviated debilitating side effects in more than 46 percent.

Life

Arts and Humanities

Keywords:

Rutgers’ New Jersey International Film Festival Turns 20

FeatureImageLocopy.jpg

New Jersey International Film Festival, based at Rutgers University, has introduced audiences to hundreds of films not seen elsewhere. It celebrates its 20th anniversary this summer.

Science

Channels:

Keywords:

Hormone ‘Erases’ Male Smell for Female Mice

dey_stowers.jpg

Scientists at The Scripps Research Institute have found that state-specific odor “blindness” exists in female mice, who cannot sense the odor of male mice when in diestrus, the period of sexual inactivity during the reproductive cycle, pointing to new avenues for studying senses and behavior.

Medicine

Keywords:

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 10-Jun-2015 8:00 AM EDT

Business

Channels:

A Texas-Size Solution for Corporate America's R&D Needs

UTSystemresearcher.jpeg

The UT System recently launch a database to help solve Corporate America's R&D needs. Influuent is the gateway to more than 15,000 UT System researchers who have produced nearly 110,000 publications in the last five years in science, medicine, engineering, technology, etc. - as well as unique research facilities throughout the UT System's campuses and institutions - including UT Austin and UT MD Anderson.

Science

Channels:

Keywords:

Feds send strong message in Ulbricht sentence, but will it deter copycats? Probably not. -- @DLDolliver

Dolliver_Diana-2013.jpg